Open1.160 | Close1.050 |
Vol / Avg.145.730K / 170.683K | Mkt Cap63.332M |
Day Range1.030 - 1.160 | 52 Wk Range0.535 - 2.840 |
Connect Biopharma Hldgs Stock (NASDAQ: CNTB) stock price, news, charts, stock research, profile.
Open1.160 | Close1.050 |
Vol / Avg.145.730K / 170.683K | Mkt Cap63.332M |
Day Range1.030 - 1.160 | 52 Wk Range0.535 - 2.840 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-13 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 5.00 |
2023-02-08 | SVB Leerink | Thomas Smith | Maintains | Outperform | Lowers | 9.00 | 7.00 |
2022-06-02 | Cantor Fitzgerald | Louise Chen | Initiates Coverage On | Overweight | Announces | - | 5.00 |
2022-05-05 | Piper Sandler | Joseph Catanzaro | Downgrades | OverweightNeutral | Lowers | 25.00 | 1.50 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CNTB | Connect Biopharma Hldgs | 0% | 63.3M |
SYRS | Syros Pharmaceuticals | 6.91% | 61.9M |
KZR | Kezar Life Sciences | 1.48% | 61.8M |
ESLA | Estrella Immunopharma | -14.2% | 51M |
CLGN | CollPlant Biotechnologies | -1.1% | 62.1M |
You can purchase shares of Connect Biopharma Hldgs (NASDAQ: CNTB) through any online brokerage.
Other companies in Connect Biopharma Hldgs’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), CollPlant Biotechnologies (NASDAQ:CLGN) and Eliem Therapeutics (NASDAQ:ELYM).
The latest price target for Connect Biopharma Hldgs (NASDAQ: CNTB) was reported by Cantor Fitzgerald on Wednesday, September 13, 2023. The analyst firm set a price target for 5.00 expecting CNTB to rise to within 12 months (a possible 334.78% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Connect Biopharma Hldgs (NASDAQ: CNTB) is $1.15 last updated December 1, 2023 at 2:28 PM UTC.
There is no dividend information for Connect Biopharma Hldgs.
Connect Biopharma Hldgs’s H1 earnings are confirmed for Tuesday, September 12, 2023.
There is no upcoming split for Connect Biopharma Hldgs.
Connect Biopharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.